Early-Stage drug safety trial halted: no direct patient benefit
NCT ID NCT06381466
First seen Sep 30, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This early-phase study tested the safety and how the body processes a new drug called AZD0233 in healthy adults aged 18 to 50. The trial was stopped early and did not involve people with the heart condition it was being developed for. The main goal was to check for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DILATED CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.